AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
5.38
+0.02 (0.37%)
At close: Aug 7, 2025, 4:00 PM
3.460
-1.920 (-35.69%)
Pre-market: Aug 8, 2025, 7:39 AM EDT
MorphoSys AG Revenue
AVITA Medical had revenue of $18.42M in the quarter ending June 30, 2025, with 21.21% growth. This brings the company's revenue in the last twelve months to $74.88M, up 38.32% year-over-year. In the year 2024, AVITA Medical had annual revenue of $64.25M with 28.14% growth.
Revenue (ttm)
$74.88M
Revenue Growth
+38.32%
P/S Ratio
1.88
Revenue / Employee
$288,015
Employees
260
Market Cap
142.91M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 64.25M | 14.11M | 28.14% |
Dec 31, 2023 | 50.14M | 15.72M | 45.68% |
Dec 31, 2022 | 34.42M | 1.40M | 4.23% |
Dec 31, 2021 | 33.03M | 3.79M | 12.98% |
Jun 30, 2021 | 29.23M | 14.97M | 104.95% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
RCEL News
- 15 hours ago - AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation - GlobeNewsWire
- 10 days ago - AVITA Medical to Announce Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards - GlobeNewsWire
- 3 months ago - AVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - AVITA Medical Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - AVITA Medical to Announce First Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025 - GlobeNewsWire
- 4 months ago - AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity - GlobeNewsWire